Protalix Biotherapeutics Inc PLX:NYSE American

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 10:00 AM EDT
1.05UNCH (UNCH)
Volume
32,580
52 week range
0.70 - 2.00
Loading...
  • Open1.05
  • Day High1.08
  • Day Low1.05
  • Prev Close1.05
  • 52 Week High2.00
  • 52 Week High Date04/04/22
  • 52 Week Low0.70
  • 52 Week Low Date02/24/22

Key Stats

  • Market Cap50.73M
  • Shares Out48.71M
  • 10 Day Average Volume0.12M
  • Dividend-
  • Dividend Yield-
  • Beta1.03
  • YTD % Change27.45

KEY STATS

  • Open1.05
  • Day High1.08
  • Day Low1.05
  • Prev Close1.05
  • 52 Week High2.00
  • 52 Week High Date04/04/22
  • 52 Week Low0.70
  • 52 Week Low Date02/24/22
  • Market Cap50.73M
  • Shares Out48.71M
  • 10 Day Average Volume0.12M
  • Dividend-
  • Dividend Yield-
  • Beta1.03
  • YTD % Change27.45

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date11/14/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Protalix Biotherapeutics Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Protalix Biotherapeutics Inc is an Israel-based biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx plant cell-based protein expression system. Its system represents a new method for developing recombinant proteins in an industrial-scale manner. Company's aim is to develop tailored complex recombinant therapeutic proteins primarily produced through ProCellEx...
Zeev Bronfeld
Independent Chairman of the Board
Dror Bashan
President, Chief Executive Officer, Director
Eyal Rubin
Chief Financial Officer, Senior Vice President, Treasurer, Secretary
Address
2 Snunit St., Science Park, POB 455
Karmiel
2161401
Israel

Top Peers

SYMBOLLASTCHG%CHG
MTEM
Molecular Templates Inc
0.75+0.0288+3.99%
TKNO
Alpha Teknova Inc
3.71+0.21+6.13%
SURF
Surface Oncology Inc
1.15+0.06+5.50%
CDTX
Cidara Therapeutics Inc
0.6011+0.051+9.27%
ORGS
Orgenesis Inc
1.45+0.05+3.57%